https://www.businesswire.com/news/home/20251204253955/en/IDE034-a-Bispecific-ADC-Licensed-by-Biocytogen-to-IDEAYA-Receives-FDA-IND-Clearance
IDE034, a Bispecific ADC Licensed by Biocytogen to IDEAYA, Receives FDA IND Clearance
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), announced that its partner IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a precision onc...